General Cardiology Fellows
Ning "Maggie" Ning, MD, PharmD
Dr. Ning was born in China and grew up in Texas. She completed her Doctor of Pharmacy with highest academic honors at UT Austin College of Pharmacy and her Doctor of Medicine at UT Southwestern Medical Center. She completed her Internal Medicine Residency at Stanford and as a medicine resident, she received the Stanford Internal Medicine Clinical Decision-Making Award and the Julian Wolfsohn Award for Outstanding Performance Resident of the year award. She continued her Cardiovascular Fellowship at Stanford and after her chief fellow year, she plans to pursue additional subspecialty training in intervention cardiology.
Pablo Sanchez, MD
Dr. Pablo Sanchez is cardiovascular medicine fellow at Stanford University. He earned a degree in physiology at The University of Arizona and received his M.D. from The University of Arizona College of Medicine, in Tucson. He completed Internal Medicine training at Brigham & Women's Hospital, and served as Chief Resident from 2018-2019. During residency, his research focused on clinical outcomes of the complex patient composition in the modern Cardiac Intensive Care Unit. During fellowship, he is interested in the cardio-pulmonary interactions of the Acute Respiratory Distress Syndrome (ARDS). Under the tutelage of Dr. Angela Rogers (Pulmonary Medicine Division) and Dr. Euan Ashley (Cardiovascular Medicine Division), he plans to integrate of immune-metabolic biomarkers and cardiac dysfunction in ARDS to evaluate clinical outcomes. After cardiology fellowship, he plans on pursuing additional fellowship training in critical care.
Shire Beach, MD
Shire was born and raised in Livermore, California. After graduating with a degree in biology from Stanford, she spent a year working in the San Francisco public school system as a member of AmeriCorps. She went on to attend medical school at UCSF and completed her residency training in internal medicine at UCLA. At UCLA, she conducted research investigating the impact of fungal prophylaxis on chronic lung allograft dysfunction as well as issues impacting women, both as providers and patients, in cardiovascular medicine. Shire is thrilled to return to Stanford for cardiology fellowship and plans to pursue a career in advanced heart failure and transplant cardiology. In her time away from the hospital, she enjoys Nora Ephron movies, musical theater, creative writing, and narrative medicine.
Yaanik Desai, MD
Yaanik grew up in Atlanta, Georgia and studied biomedical engineering at the University of Pennsylvania, where he conducted research in single-cell biology under Dr. Arjun Raj. He returned to Atlanta to attend medical school at Emory University, where he investigated outcomes from atrial fibrillation ablation and ICD extraction procedures under Dr. Faisal Merchant. He completed his internal medicine training at UCSF, where he studied the association between high-sensitivity troponin and cardiovascular outcomes under the mentorship of Dr. Rakesh Mishra and Dr. Nelson Schiller. He served as Chief Resident at UCSF from 2020-2021. He plans to pursue a career in academic cardiology, and he is broadly interested in the applications of deep learning in arrhythmia research. Outside of work, he is passionate about food and wine.
Zaniar Ghazizadeh, MD
Dr. Zaniar Ghazizadeh completed his Internal Medicine training at Yale New Haven Hospital/Yale School of Medicine. He received his medical degree from Tehran University of Medical Sciences and spent a few years as a post-doctoral fellow at Weill Cornell Medicine and Brigham and Women’s Hospital before his residency. His research interest lies in the development of in vitro and in vivo platforms for studying heart regeneration and precision medicine. Dr. Ghazizadeh’s work is focused on identifying the mechanisms of cardiac arrhythmias using several experimental systems ranging from genetically engineered animal models to human pluripotent stem cell derived cardiac cell types. His ultimate goal as a clinician-scientist is to utilize this framework for drug discovery and identifying new therapeutic strategies that can prevent or reverse specific arrhythmias.
Sneha Jain, MD, MBA
Dr. Sneha Shah Jain grew up in Naperville, Illinois and attended Duke University, where she studied Economics. Between her third and fourth years of medical school at Johns Hopkins, Dr. Jain pursued an MBA at Harvard Business School. She subsequently worked at Moderna Therapeutics and Flare Capital prior to starting internal medicine residency at NewYork-Presbyterian/Columbia. During residency, Dr. Jain was selected as a Silverman Fellow in Healthcare Innovation. In this capacity, she worked with clinical and data science partners to build and deploy the technological infrastructure to identify patients with certain cardiac conditions earlier in the course of their disease. Her research and entrepreneurial interests focus on the use of digital health and machine learning to reimagine healthcare delivery models and improve patient outcomes in cardiology
Daniel Kim, MD, PhD
Dr Dan Seung Kim was born and raised in Seattle, WA. He received his M.D. from the University of Michigan, graduating AOA, cum laude, and cum laude traditionis causa. During his medical training, he also received a Ph.D. in Genome Sciences and M.P.H. in Biostatistics, working on lipid metabolism genetics with Gail P Jarvik and later, Elizabeth Speliotes and Mike Boehnke. Dan completed his residency in Internal Medicine at Stanford as part of the Translational Investigator Program. As a fellow, he plans to work in multi-omics studying the physiologic response of the body to exercise, particularly in the setting of metabolic disease. Further information on his research is available on his Google Scholar (https://scholar.google.com/citations?user=-BS4U9IAAAAJ&hl=en).
Alexandra Steverson, MD, MPH
Dr. Alexandra Steverson grew up in New London, New Hampshire and attended Bates College in Maine where she majored in biochemistry with a concentration in public health. She completed her MD/MPH degree at Northwestern University’s Feinberg School of Medicine and performed cardiovascular epidemiology research with Drs. Donald Lloyd-Jones and Matthew Feinstein, creating a novel electronic cohort to study heart failure in HIV patients. She attended UCSF for her internal medicine residency and studied heart failure readmissions in a safety-net population. She hopes to apply her research interests in health care systems, disparities and implementation science as she pursues a career in heart failure and transplant cardiology.
David Wang, MD
David grew up in Houston, Texas. He graduated from Johns Hopkins University with a BA in public health (phi beta kappa). He received his MD from Harvard Medical School. He trained in internal medicine residency at the Brigham and Woman’s Hospital. He pursued research in (1) cardiovascular outcomes with Dr. Deepak Bhatt (2) cardiogenic shock with Dr. Ajar Kochar and (3) bedside procedure services with Dr. Majid Shafiq. He also completed the management and leadership pathway (MLP).
He is interested in interventional cardiology, cardiogenic shock, and mechanical circulatory support. He is also interested in medical education, specifically in bedside procedural training among medicine trainees.
Ramzi Dudum, MD
Dr. Ramzi Dudum grew up in San Francisco, CA, before attending UCLA for his undergraduate studies. He then traveled east to Washington, DC and Baltimore, MD where he completed medical school at George Washington University and his master’s in public health at Johns Hopkins. He stayed at Johns Hopkins, completing his internal medicine training in the Osler Residency Program and worked with Drs. Roger Blumenthal and Michael Blaha researching cardiovascular prevention, screening, and risk-prediction. Now a cardiology fellow at Stanford, he plans to continue this work as a physician-scientist.
Daniel Li, MD
Dr. Daniel Li was born in China and immigrated to the Bay Area at a young age. He attended college at the University of California San Diego where he began his research career studying cytoskeletal proteins involved in cardiomyopathies. He then worked at the National Institutes of Health prior to attending medical school at the Cleveland Clinic Lerner College of Medicine. There, he studied the mechanisms linking diet, microbiome and cardiovascular disease using a systems biology approach and continued this research through the Sarnoff Cardiovascular Research Fellowship. Daniel plans to pursue an academic career with the goal of developing a translational program using a systems approach to identify novel biomarkers that impact cardiovascular disease.
Diana Melo, MD
Dr. Diana Melo was born in Palmira, Colombia and grew up in Valley Stream, NY. She attended Stony Brook University and majored in biochemistry with a double minor in bioengineering and chemistry. She graduated Summa Cum Laude and with departmental honors. While at Stony Brook University, Diana was in the Women in Science and Engineering (WISE) program and participated in several mentoring programs working with high school and middle school girls to expose them to topics in science, technology and engineering, a mission that she continues to be passionate about. Diana earned her medical degree from New York University. During medical school, she spent an extra year working at the Heart, Lung and Blood Institute as part of the Medical Research Scholars Program at the NHI where she studied the cardiovascular complications of Erdheim-Chester Disease. She attended UCSF for Internal medicine residency where she solidified her interest in cardiology especially through various research projects, including a project studying the use of cardiovascular MRA with ferumoxytol enhancement for TAVR planning in patients with renal insufficiency. She is interested in pursuing a career in interventional cardiology.
Kaylin Nguyen
Dr. Kaylin Nguyen grew up in Orange County, California. She attended college at UCLA, where she majored in Microbiology, Immunology and Molecular Genetics. She completed both her MD and Internal Medicine training at UCSF. She has research experience in atrial fibrillation risk factors, cardiometabolic consequences of psychiatric medication use, and mobile and digital health. She plans to pursue an academic career with a focus on health disparities and digital health.
Brian Palmisano, MD, PhD
Dr. Brian Palmisano grew up in Quakertown, PA and went to University of Rochester where he majored in Biochemistry and Chemistry. After college, Brian spent a year at the National Institutes of Health before going to Vanderbilt University School of Medicine, where he completed the MD-PhD program. He completed his PhD under the mentorship of Dr. John Stafford. His thesis explored novel pathways of lipid metabolism with an emphasis on the influence of sex hormone signaling. He also worked on understanding novel pathways of selective insulin resistance and its impact on total body glucose and lipid metabolism. Dr. Palmisano completed his residency in Internal Medicine at Stanford through the Translational Investigator Pathway. Dr. Palmisano’s research interests are centered on using metabolism to validate novel targets identified through genetic and genomic screens. His ultimate goal is to identify new therapeutic targets to prevent atherosclerotic cardiovascular disease. Dr. Palmisano’s clinical interests are in Preventative Cardiology.
Krishna Pundi, MD
Dr. Krishna Pundi was born in India and immigrated to Minnesota at the age of 10, where he studied Neuroscience at the University of Minnesota and received his MD from Mayo Medical School. He completed his internal medicine training at Stanford and subsequently spent a year as the post-doctoral research fellow for the ENGAGE-AF clinical trial at Stanford working to improve shared decision-making in atrial fibrillation care. Krishna hopes to develop the skills to become an electrophysiologist and independent researcher of arrhythmia outcomes focusing on (1) improving patient risk stratification for complex therapeutic decision-making, (2) differential outcomes of frail and multi-morbid populations, and (3) gaps in guideline-based arrhythmia care through both retrospective and prospective studies.
Natalie Tapaskar, MD
Dr. Natalie Tapaskar grew up in both Toronto and Chicago and attended college at Northwestern University. She received her MD from Case Western Reserve School of Medicine and completed her Internal Medicine training at The University of Chicago. Her research focuses include risk stratification tools for patients on anticoagulation and quality improvement interventions. She hopes to pursue advanced heart failure with a focus on socioeconomic disparities and improvement of coordination of care.
Caitlin Bell, MD
Dr. Caitlin Bell was born and raised in Denver, Colorado and attended college at the University of Colorado - Boulder where she had the opportunity to work with Dr. Tom Cech investigating telomerase biochemistry. She completed her MD at Vanderbilt University Medical School, during which she spent a year as a Howard Hughes Medical Investigator research fellow researching melanoma genesis through the lens of genetics and stem cell biology. She then trained in internal medicine at Stanford University Hospital before continuing her clinical training in cardiology. She plans to pursue a career as a physician-scientist, leveraging her prior research experiences to investigate the process of atherogenesis and determinants of smooth muscle cell fates leading to clinically significant vascular disease.
Aly Elezaby, MD, PhD
Dr. Aly Elezaby attended college at the University of Arizona, where he studied molecular and cellular biology. He graduated from the MD-PhD program at Boston University, with a dissertation focus on the effects of diet on mitochondrial function and oxidative stress in the heart. He completed residency training in internal medicine at Stanford as part of the Translational Investigator Program, and intends to pursue a career studying cardiac metabolism with a clinical focus on heart failure.
Jeffrey Lin, MD
Dr. Jeff Lin grew up near Stanford and attended Northwestern University's combined BA/MD program. He completed his internal medicine residency and a chief residency at the University of Wisconsin. His interest in electrophysiology began in medical school with his research on AF ablation outcomes. During residency, his work broadened to include device-related outcomes including the identification of predictors for CRT response and procedural aspects of CIED implantation. At Stanford, he is currently involved in projects related to AF detection and clinical characteristics of silent AF. He plans to pursue an academic career in clinical electrophysiology with a particular interest in AF and heart failure outcomes.
Ning "Maggie" Ning, MD, PharmD
Dr. Ning was born in China, but she grew up mostly in Texas. She went to the University of Texas at Austin for undergrad and received her PharmD degree at the College of Pharmacy. She received her MD degree from UT Southwestern Medical Center and moved to California for Internal Medicine residency at Stanford. Dr. Ning plans to continue her training as a cardiology fellow at Stanford. She is passionate about both cardiology and oncology and thoroughly enjoys taking care of these patient populations. Subsequently, she has completed several research projects and publications in both fields. She hopes to combine her clinical and research interests by contributing to the growth of the field of cardio-oncology. She hopes she can also use her pharmacology background to better understand the complex pharmacokinetics and pharmacodynamics involving oncology therapies and cardiotoxicity. She is particularly interested in the role of noninvasive imaging to help identify these patients that may be at risk for cardiotoxicity.
Pablo Sanchez, MD
Dr. Pablo Sanchez is cardiovascular medicine fellow at Stanford University. He earned a degree in physiology at The University of Arizona and received his M.D. from The University of Arizona College of Medicine, in Tucson. He completed Internal Medicine training at Brigham & Women's Hospital, and served as Chief Resident from 2018-2019. During residency, his research focused on clinical outcomes of the complex patient composition in the modern Cardiac Intensive Care Unit. During fellowship, he is interested in the cardio-pulmonary interactions of the Acute Respiratory Distress Syndrome (ARDS). Under the tutelage of Dr. Angela Rogers (Pulmonary Medicine Division) and Dr. Euan Ashley (Cardiovascular Medicine Division), he plans to integrate of immune-metabolic biomarkers and cardiac dysfunction in ARDS to evaluate clinical outcomes. After cardiology fellowship, he plans on pursuing additional fellowship training in critical care.
James Tooley III, MD
Dr. James Tooley was born and raised in Tucson, Arizona. He attended Johns Hopkins University where he graduated with honors with a degree in Biophysics. He received his MD and MHS from Yale School of Medicine, where he graduated cum laude and was a Howard Hughes Medical Institute research fellow. He completed his Internal Medicine residency training at Stanford. He is interested electrophysiology, ECGs, and research using the electronic healthcare record. James plans to have an academic career as a clinical investigator practicing electrophysiology.
Chad Weldy, MD, PhD
Dr. Chad Weldy received his MD from Duke University and came to Stanford as an internal medicine resident and member of the Stanford Translational Investigator Program (TIP). Prior to medical school, Dr. Weldy completed his PhD in Toxicology at the University of Washington (UW) where his research focused on genetic determinants of antioxidant biosynthesis, redox biology, and vascular function in response to inhaled toxicants. Dr. Weldy then completed a postdoctoral fellowship at the UW Division of Cardiology where he studied the relationship between cardiac development and adult heart failure. His work led to the discovery that in utero exposure to air pollution increases adult susceptibility to heart failure in mice. As a resident at Stanford, he has conducted research investigating how global profiles of circulating miRNA can predict RV failure in adult patients with tetralogy of Fallot. Dr. Weldy plans a career as an academic clinical cardiologist and basic scientist with the goal of elucidating novel mechanisms of disease by characterizing the relationship between the developing heart and adult cardiovascular disease.